Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1991 Apr;31(4):429–432. doi: 10.1111/j.1365-2125.1991.tb05558.x

Cerebral blood flow and indomethacin drug levels in subjects with and without central nervous side effects.

P Seideman 1, M von Arbin 1
PMCID: PMC1368330  PMID: 2049252

Abstract

1. Central nervous system (CNS) side effects are observed during treatment with all nonsteroidal anti-inflammatory drugs (NSAIDs) but their effects are more common during treatment with indomethacin. 2. The aim of the study was to elucidate the mechanism of the CNS related side effects of indomethacin. Two groups were obtained, one with (n = 11), and one without (n = 7), CNS symptoms. Cerebral blood flow was measured in these groups with Doppler equipment, indomethacin levels with h.p.l.c. and CNS symptoms graded on a VAS scale. 3. Blood flow was reduced by 18-30% and was most marked 60 min after dose and did not differ between the two groups. The maximum CNS effect coincided with indomethacin peak levels 60-70 min after dose. These results could implicate that CNS symptoms may be related to indomethacin levels in sensitive patients.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abdel-Halim M. S., von Holst H., Meyerson B., Sachs C., Anggård E. Prostaglandin profiles in tissue and blood vessels from human brain. J Neurochem. 1980 May;34(5):1331–1333. doi: 10.1111/j.1471-4159.1980.tb09980.x. [DOI] [PubMed] [Google Scholar]
  2. Bill A. Effects of indomethacin on regional blood flow in conscious rabbits--a microsphere study. Acta Physiol Scand. 1979 Apr;105(4):437–442. doi: 10.1111/j.1748-1716.1979.tb00108.x. [DOI] [PubMed] [Google Scholar]
  3. Boullin D. J., Bunting S., Blaso W. P., Hunt T. M., Moncada S. Responses of human and baboon arteries to prostaglandin endoperoxides and biologically generated and synthetic prostacyclin: their relevance to cerebral arterial spasm in man. Br J Clin Pharmacol. 1979 Feb;7(2):139–147. doi: 10.1111/j.1365-2125.1979.tb00914.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cook P. J., Maidment C. G., Dandona P., Hutton R. A., James I. M. The effect of intravenous epoprostenol (prostacyclin, PGI2) on cerebral blood flow and cardiac output in man. Br J Clin Pharmacol. 1983 Dec;16(6):707–711. doi: 10.1111/j.1365-2125.1983.tb02245.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crockard A., Iannotti F., Ladds G. Cerebrovascular effects of prostaglandin inhibitors in the gerbil. J Cereb Blood Flow Metab. 1982;2(1):67–72. doi: 10.1038/jcbfm.1982.7. [DOI] [PubMed] [Google Scholar]
  6. Eriksson S., Hagenfeldt L., Law D., Patrono C., Pinca E., Wennmalm A. Effect of prostaglandin synthesis inhibitors on basal and carbon dioxide stimulated cerebral blood flow in man. Acta Physiol Scand. 1983 Feb;117(2):203–211. doi: 10.1111/j.1748-1716.1983.tb07198.x. [DOI] [PubMed] [Google Scholar]
  7. Leffler C. W., Busija D. W., Fletcher A. M., Beasley D. G., Hessler J. R., Green R. S. Effects of indomethacin upon cerebral hemodynamics of newborn pigs. Pediatr Res. 1985 Nov;19(11):1160–1164. doi: 10.1203/00006450-198511000-00009. [DOI] [PubMed] [Google Scholar]
  8. Lindegaard K. F., Lundar T., Wiberg J., Sjøberg D., Aaslid R., Nornes H. Variations in middle cerebral artery blood flow investigated with noninvasive transcranial blood velocity measurements. Stroke. 1987 Nov-Dec;18(6):1025–1030. doi: 10.1161/01.str.18.6.1025. [DOI] [PubMed] [Google Scholar]
  9. Melsom M., Laake K. Neuropsykiatrisk bivirkning av indometacin. Tidsskr Nor Laegeforen. 1979 Feb 28;99(6):318–319. [PubMed] [Google Scholar]
  10. Perlman J. M., Hill A., Volpe J. J. The effect of patent ductus arteriosus on flow velocity in the anterior cerebral arteries: ductal steal in the premature newborn infant. J Pediatr. 1981 Nov;99(5):767–771. doi: 10.1016/s0022-3476(81)80408-8. [DOI] [PubMed] [Google Scholar]
  11. Pryds O., Greisen G., Johansen K. H. Indomethacin and cerebral blood flow in premature infants treated for patent ductus arteriosus. Eur J Pediatr. 1988 Apr;147(3):315–316. doi: 10.1007/BF00442705. [DOI] [PubMed] [Google Scholar]
  12. Pullar T., Myall O., Haigh J. R., Lowe J. R., Dixon J. S., Bird H. A. The effect of indomethacin on the psychomotor function of patients with rheumatic diseases. Br J Rheumatol. 1988 Jun;27(3):227–229. doi: 10.1093/rheumatology/27.3.227. [DOI] [PubMed] [Google Scholar]
  13. Rane A., Oelz O., Frolich J. C., Seyberth H. W., Sweetman B. J., Watson J. T., Wilkinson G. R., Oates J. A. Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin Pharmacol Ther. 1978 Jun;23(6):658–668. doi: 10.1002/cpt1978236658. [DOI] [PubMed] [Google Scholar]
  14. Siesjö B. K., Nilsson B. Prostaglandins and the cerebral circulation. Adv Prostaglandin Thromboxane Leukot Res. 1982;10:367–380. [PubMed] [Google Scholar]
  15. Wåhlin-Boll E., Brantmark B., Hanson A., Melander A., Nilsson C. High-pressure liquid chromatographic determination of acetylsalicylic acid, salicylic acid, diflunisal, indomethacin, indoprofen and indobufen. Eur J Clin Pharmacol. 1981;20(5):375–378. doi: 10.1007/BF00615408. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES